The STEP-2 25 and STEP-6 studies 25 supported these findings, showing higher incidences of psychiatric events with higher doses of semaglutide
PVN, paraventricular nucleus
In one alarming case from February 2024, a patient consuming only 400600 calories daily, along with minimal fluids, ended up hospitalized for acute kidney injury
The Glucagon Paradox The glucagon paradox refers to the unexpected possibility that a hormone traditionally associated with raising blood glucose may enhance weight loss when incorporated into balanced multi-receptor agonists
When the thyroid releases T4, the body has to convert it into T3 in order to use it
As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so too does our knowledge of just what all these medications can do